- Migraine biotech Vedana Therapeutics makes its debut with $46M Series AVedana Therapeutics has emerged from stealth with $46 million in Series A proceeds with the goal of developing treatments that could free patients from migraines entirely. Available treatments fo…Endpoints · 1mo ago↗ source
- Opinion: As a physician, I have never been more concerned about rates of congenital syphilis“As a physician and former public health official, I have never been more concerned about those rates of congenital syphilis,” writes Jeffrey D. Klausner.STAT · 1mo ago↗ source
- Opinion: The quiet joy of being an oncologist“The privilege of oncology is not only that you get to cure people,” writes oncologist Khushali Jhaveri. “It is also that you are invited into the most honest rooms in…